secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001437749-24-001579
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Talphera sells DSUVIA/DZUVEO royalty rights to XOMA for $8M upfront
-------------------------------------------------------------------

- Sold rights to royalty and milestone payments from Vertical Pharma to XOMA for $8M cash.
- Potential milestones up to $116.5M based on net sales; Talphera retains partial rights after stepdown.
- Stepdown occurs when XOMA receives a minimum payment amount; specific amount not disclosed.
- After stepdown: Talphera keeps 50% of DoD sales royalties and milestones; XOMA gets 100% non-DoD.
- Agreement includes customary reps, warranties, and indemnification obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774924001579/0001437749-24-001579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774924001579/acrx20240117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer